Embera NeuroTherapeutics, Inc. Closes Series A Funding, Starting FDA Trial Process

More info…

Embera NeuroTherapeutics, Inc., a start-up company developing novel treatments for a broad range of addictions, as well as other neuropsychiatric disorders, has secured over $800,000 of Series A financing that will help the company move its novel combinational drug into Phase 1b FDA trials.

(PRWeb February 08, 2007)

Read the full story at

meth rehab center

Posted in Alcohol Rehab Center  |  Leave a comment

Leave a reply